Skip to content
TrialScanner

NCT05581199

To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP

Phase 2TerminatedIMVTLead

Registry record

Lead sponsor
Immunovant Sciences GmbH
Conditions
Chronic Inflammatory Demyelinating Polyneuropathy
Primary completion
Jul 20, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05581199 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.